Biotech Companies

The Stem Cell Network strengthens Canada’s regenerative medicine ecosystem by supporting innovative biotech companies. Through its Commercialization Readiness Program, SCN provides funding, practical tools, guidance, and resources to help companies advance technologies, develop commercialization strategies, and safeguard research. With over $162M invested in research projects and clinical trials across Canada, SCN has supported approximately two dozen biotech companies, strengthening existing firms and enabling the creation of new spin-outs.

Resources for SCN’s Incubation Investment Award Applicants

Incubation Investment Award – Program Overview

An SCN funding initiative designed to help Canadian regenerative medicine biotech companies advance their technologies toward commercialization.

Incubation Investment Award – FAQs

Answers to common questions about eligibility, application requirements, and evaluation criteria for SCN’s Incubation Investment Award.

Incubation Investment Award – Informational Video

An informational video outlining the purpose, process, and benefits of SCN’s Incubation Investment Award for biotech companies.

Incubation Investment Award – Slide Deck

A downloadable version of the presentation slides from the Incubation Investment Award information session, outlining key program details and application requirements.

Technology Commercialization Readiness Resources

Technology Commercialization Readiness Guide

An overview of key considerations for translating regenerative medicine innovations from the lab to the marketplace.

Early Considerations for Commercialization

A checklist to guide early-stage discussions with your Technology Transfer Office (TTO) when disclosing a new invention.

Technology Readiness Assessment

A guide to help assess a technology’s maturity and identify the steps needed to move toward commercialization.

Inventions and Working with Your Technology Transfer Office: FAQs

Answers to common questions about invention disclosure and collaborating with your Technology Transfer Office.

Technology Commercialization Readiness Guide Video

A short explainer video introducing the Technology Commercialization Readiness Guide.

Tools for Cell Therapy Development

Target Product Profile (TPP) Template and Guide

A step-by-step template and instructions to help researchers define the commercial goals of their cell therapy and prepare for the regulatory pathway ahead.

Quality Target Product Profile (QTPP) Template and Guide

A structured tool for assessing key manufacturing considerations and quality attributes critical for advancing a cell therapy toward clinical use.

Instructional Video with Patrick Bedford, WeCanReg

An overview video featuring regulatory expert Patrick Bedford, offering guidance on how to effectively complete and apply the TPP and QTPP tools.

Research Security Resources

SCN’s Research Security Policy

Guidance on SCN's research security requirements and best practices.

Sensitive Technology Research Areas

A Government of Canada listing of sensitive technology research areas important to Canada that may be targeted by foreign or non-state actors.

Policy on Sensitive Technology Research and Affiliations of Concern (STRAC)

A Government of Canada policy providing guidance for safeguarding sensitive technology research and maintaining secure, responsible collaborations.

National Security Guidelines for Research Partnerships (NSGRP)

A set of Government of Canada guidelines to integrate national security considerations into the development, evaluation, and funding of research partnerships.

Other Resources

Webinars and Presentations of Interest

A curated YouTube playlist of SCN’s research webinars and presentations relevant for bio-entrepreneurs.

Stem Cell Network’s Logo

SCN’s high-resolution logo for use on slides, posters, and other materials to acknowledge SCN as a funder.

Travel Claim Form

A form to submit claims for travel supported by SCN.